Research Article
Prognosis Risk of Urosepsis in Critical Care Medicine: A Prospective Observational Study
Table 3
Subgroup analysis of urosepsis patients.
| | Transferred from the department of urinary surgery () | Transferred from other departments () | | value |
| Time before being sent to ICU (hours) | 11.6 ± 7.3 | 7.2 ± 4.9 | 2.239 | 0.032 | Positive blood culture rate | 14 (82%) | 13 (68%) | 0.929 | 0.335 | Percentage with combination diseases | 5 (29%) | 11 (58%) | 2.948 | 0.086 | SOFA score | 5.7 ± 2.1 | 6.0 ± 1.8 | −0.462 | 0.647 | APACHE II score | 18.8 ± 6.2 | 22.4 ± 5.6 | −1.831 | 0.076 | Mechanical ventilation | 9 (53%) | 11 (58%) | 0.089 | 0.765 | CRRT | 4 (24%) | 6 (31%) | 0.290 | 0.590 | Vasoactive drugs use | 8 (47%) | 9 (47%) | <0.001 | 0.985 | WBC count (×109/L) | 5.9 ± 5.1 | 6.4 ± 5.7 | −0.276 | 0.784 | PLT (×109/L) | 81.0 ± 35.6 | 85.7 ± 32.3 | −0.415 | 0.680 | MAP (mmHg) | 89.4 ± 20.5 | 93.2 ± 18.8 | −0.580 | 0.566 | Serum creatinine (μmol/L) | 123.6 ± 50.9 | 126.4 ± 48.6 | −0.169 | 0.867 | Bilirubin (μmol/L) | 16.8 ± 4.2 | 14.5 ± 3.7 | 1.747 | 0.090 | 28-day mortality | 1 (6%) | 1 (5%) | 0.007 | 0.935 | 90-day mortality | 1 (6%) | 1 (5%) | 0.007 | 0.935 |
|
|
APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment; ICU, intensive care unit; WBC, white blood cell; PLT, platelet; MAP, mean arterial pressure; CRRT, continuous renal replacement therapy.
|